About us
GPCRmd is a project developed by the
GPCR drug discovery group, located at the
PRBB, Barcelona. The
group is focussed on the functionality of G
protein coupled receptors (GPCRs) in the context of CNS-related disorders taking into
account: receptor plasticity, activation mechanism, signaling bias, ligand binding,
the effect of the membrane and other interaction partners. The final goal is to
translate obtained molecular insights into the design of drug candidates with
improved therapeutic profiles. Jana Selent
is the group leader.
GPCRmd aims to promote data sharing and reproducibility. Therefore, GPCRmd stores information
about starting structure, parameters and simulation protocols. The data will be stored for at
least 8 years after data submission.
However, there are far more GPCRmd contributors forming the
community.
The GPCRmd community
- Ismael Rodríguez-Espigares, Hospital del Mar Medical Research Institute—Pompeu Fabra University (Barcelona, Spain)
- Mariona Torrens-Fontanals, Hospital del Mar Medical Research Institute—Pompeu Fabra University (Barcelona, Spain)
- David Aranda-García, Hospital del Mar Medical Research Institute—Pompeu Fabra University (Barcelona, Spain)
- Johanna K. S. Tiemann, University of Copenhagen (Copenhagen, Denmark), Medical University Leipzig (Leipzig, Germany), Charite University Medicine Berlin (Berlin, Germany)
- Juan Manuel Ramírez-Anguita, Hospital del Mar Medical Research Institute—Pompeu Fabra University (Barcelona, Spain)
- Tomasz Maciej Stepniewski, Hospital del Mar Medical Research Institute—Pompeu Fabra University (Barcelona, Spain)
- Nathalie Worp, Hospital del Mar Medical Research Institute—Pompeu Fabra University (Barcelona, Spain)
- Alejandro Varela-Rial, Pompeu Fabra University (Barcelona, Spain)
- Adrián Morales-Pastor, Hospital del Mar Medical Research Institute—Pompeu Fabra University (Barcelona, Spain)
- Brian Medel-Lacruz, Hospital del Mar Medical Research Institute—Pompeu Fabra University (Barcelona, Spain)
- Gáspár Pándy-Szekeres, University of Copenhagen (Copenhagen, Denmark)
- Eduardo Mayol, Universitat Autònoma de Barcelona (Bellaterra, Spain)
- Toni Giorgino, National Research Council of Italy (Milan, Italy), University of Milan (Milan, Italy)
- Jens Carlsson, Uppsala University (Uppsala, Sweden)
- Xavier Deupi, Paul Scherrer Institute (Villigen PSI, Switzerland)
- Slawomir Filipek, University of Warsaw (Warsaw, Poland)
- Marta Filizola, Icahn School of Medicine at Mount Sinai (New York, USA)
- José Carlos Gómez-Tamayo, Universitat Autònoma de Barcelona (Bellaterra, Spain)
- Angel Gonzalez, Universitat Autònoma de Barcelona (Bellaterra, Spain)
- Hugo Gutiérrez-de-Terán, Uppsala University (Uppsala, Sweden)
- Mireia Jiménez-Rosés, Universitat Autònoma de Barcelona (Bellaterra, Spain)
- Willem Jespers, Uppsala University (Uppsala, Sweden)
- Jon Kapla, Uppsala University (Uppsala, Sweden)
- George Khelashvili, Weill Cornell Medical College of Cornell University (New York, USA)
- Peter Kolb, Philipps-University Marburg (Marburg, Germany)
- Dorota Latek, University of Warsaw (Warsaw, Poland)
- Maria Marti-Solano, MRC Laboratory of Molecular Biology (Cambridge, UK), Philipps-University Marburg (Marburg, Germany)
- Pierre Matricon, Uppsala University (Uppsala, Sweden)
- Minos-Timotheos Matsoukas, University of Patras (Patras, Greece), Universitat Autònoma de Barcelona (Bellaterra, Spain)
- Przemyslaw Miszta, University of Warsaw (Warsaw, Poland)
- Mireia Olivella, Universitat Autònoma de Barcelona (Bellaterra, Spain)
- Laura Perez-Benito, Universitat Autònoma de Barcelona (Bellaterra, Spain)
- Davide Provasi, Icahn School of Medicine at Mount Sinai (New York, USA)
- Santiago Ríos, Universitat Autònoma de Barcelona (Bellaterra, Spain)
- Iván R. Torrecillas, Universitat Autònoma de Barcelona (Bellaterra, Spain)
- Jessica Sallander, Uppsala University (Uppsala, Sweden)
- Agnieszka Sztyler, University of Warsaw (Warsaw, Poland)
- Silvana Vasile, Uppsala University (Uppsala, Sweden)
- Harel Weinstein, Weill Cornell Medical College of Cornell University (New York, USA)
- Ulrich Zachariae, University of Dundee (Dundee, UK)
- Peter W. Hildebrand, Medical University Leipzig (Leipzig, Germany), Charite University Medicine Berlin (Berlin, Germany), Berlin Institute of Health (Berlin, Germany)
- Gianni De Fabritiis, Pompeu Fabra University (Barcelona, Spain), Acellera (Barcelona, Spain)
- Ferran Sanz, Hospital del Mar Medical Research Institute—Pompeu Fabra University (Barcelona, Spain)
- David E. Gloriam, University of Copenhagen (Copenhagen, Denmark)
- Arnau Cordomi, Universitat Autònoma de Barcelona (Bellaterra, Spain)
- Ramon Guixà-González, Paul Scherrer Institute (Villigen PSI, Switzerland)
- Irina Tikhonova, Queen's University Belfast (Belfast, UK)
- Antonella di Pizio, Technical University of Munich (Munich, Germany)
- Alessandro Nicoli, Technical University of Munich (Munich, Germany)
- Jesper Madsen, University of South Florida (Tampa, USA)
- Célien Jacquemard, University of Strasbourg (Strasbourg, France)
- Aida Shahraki, Philipps-University Marburg (Marburg, Germany)
- Matthaeus Drabek, Philipps-University Marburg (Marburg, Germany)
- Victor Lim, Philipps-University Marburg (Marburg, Germany)
- Jana Selent, Hospital del Mar Medical Research Institute—Pompeu Fabra University (Barcelona, Spain)
